U.S. Code of Federal Regulations
Regulations most recently checked for updates: Feb 04, 2023
§ 201.302 - Notice to manufacturers, packers, and distributors of drugs for internal use which contain mineral oil.
§ 201.305 - Isoproterenol inhalation preparations (pressurized aerosols, nebulizers, powders) for human use; warnings.
§ 201.307 - Sodium phosphates; package size limitation, warnings, and directions for over-the-counter sale.
§ 201.311 - [Reserved]
§ 201.317 - Digitalis and related cardiotonic drugs for human use in oral dosage forms; required warning.
§ 201.319 - Water-soluble gums, hydrophilic gums, and hydrophilic mucilloids (including, but not limited to agar, alginic acid, calcium polycarbophil, carboxymethylcellulose sodium, carrageenan, chondrus, glucomannan ((B-1,4 linked) polymannose acetate), guar gum, karaya gum, kelp, methylcellulose, plantago seed (psyllium), polycarbophil tragacanth, and xanthan gum) as active ingredients; required warnings and directions.
§ 201.320 - Warning statements for drug products containing or manufactured with chlorofluorocarbons or other ozone-depleting substances.
§ 201.325 - Over-the-counter drugs for vaginal contraceptive and spermicide use containing nonoxynol 9 as the active ingredient; required warnings and labeling information.
§ 201.326 - Over-the-counter drug products containing internal analgesic/antipyretic active ingredients; required warnings and other labeling.
§ 201.327 - Over-the-counter sunscreen drug products; required labeling based on effectiveness testing.